Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (iv) All clients by country and rates of injection of primary drug (%)

Country		Year	Opioids % injecting	Cocaine % injecting	Amphetamines % injecting	Total % injecting
Belgium	(1)	2005	20.6	10.4	18.6	12.6
Bulgaria		2007	82.8	25.0		80.7
Czech Republic		2007	85.3	0.0	81.5	69.4
Denmark	(2)	2007	2.4	1.1	0.3	11.3
Germany	(3)	2007	42.8	25.4	2.6	17.7
Estonia		:	:	:	:	:
Ireland		2007	42.8	4.1	2.6	27.7
Greece		2007	44.1	3.3	0.0	38.2
Spain	(4)	2006	21.8	2.2	1.7	9.5
France		2007	24.9	13.1	11.8	10.6
Italy	(5)	2007	64.3	5.9	0.0	41.0
Cyprus		2007	67.2	4.2	0.0	37.5
Latvia	(6)	2007	95.6	14.3	67.8	76.8
Lithuania	(7)	2007	98.4	22.2	60.3	92.8
Luxembourg		2007	68.9	68.2	0.0	61.0
Hungary		2007	72.4	8.8	21.2	10.2
Malta	(8)	2006	75.7	30.9	0.0	60.9
Netherlands		2007	8.7	0.3	1.7	1.5
Austria	(9)	2007	47.8	9.6	1.3	32.5
Poland	(10)	2006	:	:	:	:
Portugal	(11)	2007	:	:	:	:
Romania		2007	95.1	0.0	0.0	67.6
Slovenia		2007	49.5	100.0		48.4
Slovakia		2007	82.3	0.0	40.5	47.9
Finland		2007	82.4	0.0	82.5	62.9
Sweden		2007	57.1	3.0	62.9	40.6
Uk	(12)	2007	38.5	5.2	25.4	26.0
Croatia		2007	75.4	0.7	0.0	57.9
Turkey		2007	47.8	1.0		21.1
Norway		:	:	:	:	:
Total			45.5	8.0	33.5	33.4

Notes:

 Drug specific percentages are of clients whose primary drug and usual route of administration is known. Total considers all the injection cases regardless of the primary drug being known or not. 

 Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs. 

 When proportion of clients by main drug is 0, ‘% of injectors’ is blank. If no data is available, the symbol ":" is used. 

 (1) Last data available refer to 2005. 

 (2) Most of injection cases have been reported under unknown primary drug. 

 (3) Data on amphetamines refer to stimulants in general. Data on route of administration refer to primary and non primary drugs. 

 (4) Last data available refer to 2006. 

 (5) Until 2004, ‘all clients’ reported clients continuing in or entering treatment in reported year; 2005 data are conformant with the TDI protocol. 

 (6) Data refer only to inpatient centres for which information on all clients have been reported. 

 (7) Data on amphetamines include amphetamines and ecstasy. 

 (8) Last data available refer to 2006. 

 (9) Up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006, data are based on the new DOKLI data collection system. 

 (10) No data available. 

 (11) Data only available for new clients. 

 (12) Data relate to 1 April 2006 to 31 March 2007 

 See also ‘General notes for interpreting data’ on the <a href="https://www.emcdda.europa.eu/stats09/help">Explanatory notes and help page</a>. 

Sources:

 <a href="https://www.emcdda.europa.eu/publications/national-reports">Reitox national reports 2008</a> — TDI tables V. 1.0-2007 (question 16.1.1) See <a href="https://www.emcdda.europa.eu/stats09/tditab0">Table TDI-0</a> for details on sources. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)